The interplay of effector and regulatory T cells in cancer

Current Opinion in Immunology
Rahul RoychoudhuriNicholas P Restifo

Abstract

Regulatory T (Treg) cells suppress effector T (Teff) cells and prevent immune-mediated rejection of cancer. Much less appreciated are mechanisms by which Teff cells antagonize Treg cells. Herein, we consider how complex reciprocal interactions between Teff and Treg cells shape their population dynamics within tumors. Under states of tolerance, including during tumor escape, suppressed Teff cells support Treg cell populations through antigen-dependent provision of interleukin (IL)-2. During immune activation, Teff cells can lose this supportive capacity and directly antagonize Treg cell populations to neutralize their immunosuppressive function. While this latter state is rarely achieved spontaneously within tumors, we propose that therapeutic induction of immune activation has the potential to stably disrupt immunosuppressive population states resulting in durable cancer regression.

References

Jul 14, 1977·Nature·S Gillis, K A Smith
Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·V L GodfreyL B Russell
Mar 22, 1996·Science·D R LeachJ P Allison
Oct 1, 1996·Immunological Reviews·C A ChambersJ P Allison
Mar 20, 2002·Cytokine & Growth Factor Reviews·Hiroaki IkedaRobert D Schreiber
Mar 20, 2002·Cytokine & Growth Factor Reviews·Mario P Colombo, Giorgio Trinchieri
Jan 11, 2003·Science·Shohei HoriShimon Sakaguchi
Feb 4, 2003·Nature Immunology·E John WherryRafi Ahmed
Mar 4, 2003·Nature Immunology·Jason D FontenotAlexander Y Rudensky
Mar 4, 2003·Nature Immunology·Roli KhattriFred Ramsdell
Mar 23, 2004·Annual Review of Immunology·Gavin P DunnRobert D Schreiber
Jan 26, 2005·Trends in Immunology·Christopher A KlebanoffNicholas P Restifo
Mar 9, 2005·The Journal of Experimental Medicine·Allison L BayerThomas R Malek
Oct 18, 2005·Nature Immunology·Jason D FontenotAlexander Y Rudensky
Dec 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eiichi SatoKunle Odunsi
Apr 20, 2006·Nature Reviews. Immunology·Giuseppe Pantaleo, Alexandre Harari
Jun 17, 2006·The Journal of Clinical Investigation·Sergio A QuezadaJames P Allison
Jul 11, 2006·Immunological Reviews·Christopher A KlebanoffNicholas P Restifo
Sep 27, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nobuyoshi HiraokaSetsuo Hirohashi
Dec 1, 2006·Annual Review of Immunology·Gabriel A RabinovichEduardo M Sotomayor
Dec 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gaynor J BatesAlison H Banham
May 10, 2007·Cancer Immunology, Immunotherapy : CII·Richard W GriffithsRobert E Hawkins
May 16, 2007·The Journal of Experimental Medicine·Silvia DeaglioSimon C Robson
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Qiang GaoZhao-You Tang
Nov 6, 2007·Proceedings of the National Academy of Sciences of the United States of America·Jun WeiF Xiao-Feng Qin
Mar 8, 2008·Nature Reviews. Immunology·Robert A SederMario Roederer
Apr 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ekaterina S JordanovaGert Jan Fleuren
Jun 21, 2008·Nature Reviews. Immunology·Dario A A VignaliCreg J Workman
Jul 12, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Giuseppe PerroneFrancesco Graziano
Jul 16, 2008·Melanoma Research·Louise V KalialisHelle Klyver

❮ Previous
Next ❯

Citations

Sep 10, 2015·FEBS Letters·Ada G BlidnerGabriel A Rabinovich
Jan 6, 2016·The Journal of Clinical Investigation·Rahul RoychoudhuriNicholas P Restifo
Dec 1, 2015·Cellular Immunology·Chris J C JohnstonRick M Maizels
Dec 26, 2015·Trends in Pharmacological Sciences·Daniel T Harris, David M Kranz
Nov 4, 2015·Frontiers in Immunology·Vedran BrezarNabila Seddiki
Aug 1, 2015·Human Gene Therapy·Gunilla EnbladAngelica S I Loskog
Jun 23, 2015·Immunology Letters·Maria Teresa P de AquinoAnil Shanker
Oct 25, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Francesco FacchinettiMarcello Tiseo
Aug 16, 2016·Transfusion Medicine Reviews·Bernard Khor
Oct 27, 2016·Cancers·Nicole MaedingBarbara Krammer
Apr 1, 2017·Cancer Immunology, Immunotherapy : CII·Marek K JaniakEdward J Calabrese
May 8, 2018·Scandinavian Journal of Immunology·H Bareke, J Akbuga
Apr 29, 2018·The AAPS Journal·Mohammad TabriziGlareh Azadi
Jul 11, 2018·Future Oncology·Francesco PassigliaRaffaele Conca
Jun 26, 2018·International Immunology·Kanako ShimizuShin-Ichiro Fujii
Jun 1, 2018·American Journal of Physiology. Lung Cellular and Molecular Physiology·Xiu-Zhi WuHuan-Zhong Shi
Oct 27, 2017·The Journal of Experimental Medicine·Melissa KashetaCraig J Ceol
Jan 30, 2019·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stalin ChellappaKjetil Taskén
Aug 2, 2017·Nature Immunology·Katarzyna PlacekKeji Zhao
Apr 30, 2019·Immunology·Julie StockisTimotheus Y F Halim
Jun 22, 2019·Immunology·Awen GallimoreRahul Roychoudhuri
Feb 6, 2020·British Journal of Pharmacology·Yishan YeFlorent Malard
Oct 1, 2016·Oncotarget·María Del Mar Valenzuela-MembrivesMaría Esther Fárez-Vidal
Oct 21, 2016·Melanoma Research·Ming-Sheng LimH Paul Redmond
Oct 24, 2018·Proceedings of the National Academy of Sciences of the United States of America·Angela M MagnusonChristophe Benoist
Jul 31, 2019·Scientific Reports·Tiia J HonkanenJussi P Koivunen
Jun 20, 2020·Clinical Science·Lydia Xenou, Evangelia A Papakonstanti
Apr 14, 2017·Oncoimmunology·Delia J NelsonArlene Chan
May 4, 2017·Nature Reviews. Immunology·Kazuhiko IgarashiRahul Roychoudhuri
May 29, 2018·Cancer Immunology, Immunotherapy : CII·Zhijie LinWeijuan Gong
Mar 6, 2019·Current Topics in Medicinal Chemistry·Vadim V Tarasov TarasovGjumrakch Aliev
Oct 21, 2017·Cancer Immunology, Immunotherapy : CII·Ming-Xiang ZouXiao-Ling She

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.